Follow Newser on Twitter   Friend Newser on Facebook
Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

FDA Advisory Panel Rejects Weight-Loss Drug

Possible side effects send Acomplia to the sidelines

By M. Morris,  Newser Staff

Posted Jun 14, 2007 6:41 AM CDT

(Newser) – Accomplia, a weight-loss drug marketed in 18 other countries, failed to win approval from an FDA advisory board yesterday. The 14-member panel of outside experts ruled unanimously that manufacturer Sanofi-Aventis had not dispelled concerns about the safety of the drug, whose potential side effects include...   Read full story »

COMMENTS
You need to Log in to Newser to comment. Don't have an account yet? Sign up now!
There are no comments
A snapshot of the day's best news stories.
 

More Newser Stories

FDA Panel Votes to Keep Avandia on Shelves

Americans Go Abroad, Online for New Diet Pill

ADD Meds Prescribed For Weight Loss

Our Food Labels Need to Tell Us the Bad News

Skipping That Cookie Won't Make You Lose Weight


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   BuzzFeed   |   Cracked   |   Timelines   |   Geek Sugar   |   Business Insider   |   HuffPost Entertainment